Reducing HIV-1 transmission through prevention strategies targeting HIV-1-seropositive individuals

Journal of Antimicrobial Chemotherapy

Volumn 57, Issue 2, 2006, Pages 163-166

  McClelland, R Scott ^a   Baeten, Jared M ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Antiretroviral therapy; Infectivity; Sexually transmitted diseases

Indexed keywords

ANTIRETROVIRUS AGENT;

CLINICAL TRIAL; EDITORIAL; EPIDEMIC; GENITAL SYSTEM; HEALTH CARE PLANNING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTION PREVENTION; INFECTION RISK; MUCOSA; SECRETION; SEXUALLY TRANSMITTED DISEASE; VIRUS CONCENTRATION; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; PUBLIC HEALTH; SEXUALLY TRANSMITTED DISEASES;

EID: 31544483963     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dki433     Document Type: Editorial

References (26)

1. WHO. Scaling up Antiretroviral Therapy in Resource-Limited Settings: Treatment Guidelines for a Public Health Approach. Revision 2003; 1-44. WHO, Geneva, 2003. http://www.who.int/hiv/pub/prev_care/en/ arvrevision2003en.pdf (20 October 2005, date last accessed).
2. Quinn TC, Wawer MJ, Sewankambo N et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342: 921-9.
3. Connor EM, Sperling RS, Gelber R et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331: 1173-80.
4. Musicco M, Lazzarin A, Nicolosi A et al. Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reducesthe incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission. Arch Intern Med 1994; 154: 1971-6.
5. Castilla J, del Romero J, Hernando V et al. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr 2005; 40: 96-102.
6. Zhang H, Dornadula G, Beumont M et al. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 1998; 339: 1803-9.
7. Kovacs A, Wasserman SS, Burns D et al. Determinants of HIV-1 shedding in the genital tract of women. Lancet 2001; 358: 1593-601.
8. Wawer MJ, Gray RH, Sewankambo NK et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191: 1403-9.
9. Coombs RW, Reichelderfer PS, Landay AL. Recent observations on HIV type-1 infection in the genital tract of men and women. AIDS 2003; 17: 455-80.
10. Baeten JM, Overbaugh J. Measuring the infectiousness of persons with HIV-1: Opportunities for preventing sexual HIV-1 transmission. Curr HIV Res 2003; 1: 69-86.
11. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992; 19: 61-77.
12. Rottingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: How much really is known? Sex Transm Dis 2001; 28: 579-97.
13. McClelland RS, Lavreys L, Katingima C et al. Contribution of HIV-1 infection to acquisition of sexually transmitted disease: A 10-year prospective study. J Infect Dis 2005; 191: 333-8.
14. Cohen MS, Hoffman IF, Royce RA et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 1997; 349: 1868-73.
15. McClelland RS, Wang CC, Mandaliya K etal. Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS 2001; 15: 105-10.
16. Wang CC, McClelland RS, Reilly M et al. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis 2001; 183: 1017-22.
17. Grosskurth H, Mosha F, Todd J et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995; 346: 530-6.
18. Manhart LE, Holmes KK. Randomized controlled trials of individual-level, population-level, and multilevel interventions for preventing sexually transmitted infections: What has worked? J Infect Dis 2005; 191 Suppl 1: S7-24.
19. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: A global review. J Infect Dis 2002;186 Suppl 1: S3-28.
20. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: A meta-analysis. J Infect Dis 2002; 185: 45-52.
21. Auvert B, Buve A, Ferry B et al. Ecological and individual level analysis of risk factors for HIV infection in four urban populations in sub-Saharan Africa with different levels of HIV infection. AIDS 2001; 15 Suppl 4: S15-30.
22. McClelland RS, Wang CC, Overbaugh J et al. Association between cervical shedding of herpes simplex virus and human immunodeficiency virus type 1. AIDS 2002; 16: 2425-30.
23. Celum CL, Robinson NJ, Cohen MS. Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection. J Infect Dis 2005; 191 Suppl 1: S107-14.
24. Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: A meta-analytic review. JAMA 2004; 292: 224-36.
25. Laurent C, Kouanfack C, Koulla-Shiro S et al. Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Lancet 2004; 364: 29-34.
26. UNAIDS/WHO. AIDS Epidemic Update: December 2004; 1-87. WHO, Geneva, 2004. http://www.unaids.org/wad2004/EPI_1204_pdf_en/EpiUpdate04_en.pdf (20 October 2005, date last accessed).